Deliver Your News to the World

Leading Study Linking Hormone Therapy to Breast Cancer Deemed Flawed

New research shows landmark Million Woman Study that linked hormone replacement therapy to an increased risk of breast cancer had irregularities and may be inaccurate


WEBWIRE

(MIAMI, FL) – The results of a review on the leading study establishing a link between hormone replacement therapy are in, and they’re not good. The Journal of Family Planning and Reproductive Health examined the famous Million Woman Study, and concluded that the methods used to draw conclusions in the study were so problematic that the results must be invalidated.

The Million Woman Study, so-called because it solicited results from questionnaires of more than one million women, made headlines in 2003 when it claimed that using estrogen hormone replacement therapy resulted in a 30% increase in the likelihood of breast cancer in comparison to women who didn’t receive hormone replacement therapy, and that estrogen-progesterone hormone therapy caused a 60% increase.

Amongst the issues raised with the study: failure to discount women who were diagnosed within the first few months of enrolling and thus had the condition developing prior to the study, and a participant bias. Women in the study were recruited from a breast cancer screening program, so they were much more likely to be looking for the condition, or to have already suspected its existence. The women in the Million Woman Study had a 40% higher occurrence of breast cancer than the general populace, regardless of whether they’d received hormone replacement therapy.

The resulting backlash against the treatments caused by the study led many women to not even consider hormone replacement, despite its many proven benefits. Hormone replacement therapy supplements the body’s natural hormone production, counteracting the effects of aging and menopause. In many cases, advanced hormone replacement therapy treatments like those available at cutting edge clinics like American Longevity Center can totally alleviate the negative symptoms of menopause.

Menopause is caused by the cessation of menstruation, and typically occurs in between the ages of 45 and 55. During menopause, the body cuts hormone production drastically, which causes many of the unpleasant symptoms associated with menopause. These symptoms include hot flashes, fatigue, depression, PMS-like symptoms, irritability, irregular periods, vaginal dryness, and endometriosis.

If you are suffering from menopause, don’t wait any longer. There’s no reason to accept feeling poorly as a normal part of aging when the remedy is as simple as calling the American Longevity Center.

To learn more about Hormone Replacement Therapy, visit American Longevity Center online at http://www.americanlongevitycenter.com/

About American Longevity Center:
American Longevity Center is an advanced medical facility that treats and prevents the signs and symptoms associated with aging and hormone imbalances. American Longevity Center offers hormone replacement therapy and advanced healthy aging medicine for men and women who want to look and feel their best as they age. Their medical facilities offer physician prescribed and monitored treatment programs that incorporate the latest breakthroughs in anti-aging therapies including Human Growth Hormone and Testosterone replacement treatments.

The most highly trained physicians are available for consultations and treatment at ALC.  Their doctors are nationally recognized experts in the field of anti-aging medicine and are Board Certified from the American Academy of Anti-Aging Medicine.

Please visit their website for a complete list of their healthy aging and functional medicine specialties.


 
*Article source:  http://articles.nydailynews.com/2012-01-18/news/30641194_1_hormone-therapy-million-women-study-breast-lumps
 



WebWireID152600




 
 hormone replacement
 hormone therapy
 menopause treatment
 bio identical hormones
 hormones for menopause


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.